1.83
price up icon1.10%   0.02
 
loading
Schlusskurs vom Vortag:
$1.81
Offen:
$1.8
24-Stunden-Volumen:
651.52K
Relative Volume:
0.76
Marktkapitalisierung:
$129.98M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-117.50M
KGV:
-0.7625
EPS:
-2.4
Netto-Cashflow:
$-114.31M
1W Leistung:
+2.23%
1M Leistung:
-24.07%
6M Leistung:
+4.57%
1J Leistung:
-29.89%
1-Tages-Spanne:
Value
$1.79
$1.85
1-Wochen-Bereich:
Value
$1.70
$1.85
52-Wochen-Spanne:
Value
$1.31
$3.1553

Nkarta Inc Stock (NKTX) Company Profile

Name
Firmenname
Nkarta Inc
Name
Telefon
(925) 407-1049
Name
Adresse
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
Name
Mitarbeiter
157
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-26
Name
Neueste SEC-Einreichungen
Name
NKTX's Discussions on Twitter

Vergleichen Sie NKTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NKTX
Nkarta Inc
1.83 128.56M 0 -117.50M -114.31M -2.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
432.17 109.05B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
784.61 82.75B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
445.12 56.78B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
917.63 56.52B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
204.51 44.58B 447.02M -1.18B -906.14M -6.1812

Nkarta Inc Stock (NKTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-15 Herabstufung William Blair Outperform → Mkt Perform
2024-10-09 Eingeleitet Rodman & Renshaw Buy
2024-08-14 Hochstufung Raymond James Outperform → Strong Buy
2024-03-22 Herabstufung Raymond James Strong Buy → Outperform
2022-12-22 Herabstufung Oppenheimer Outperform → Perform
2022-10-10 Eingeleitet Canaccord Genuity Buy
2022-07-28 Eingeleitet Needham Buy
2022-07-18 Eingeleitet SVB Leerink Outperform
2022-03-11 Eingeleitet Raymond James Outperform
2022-03-08 Eingeleitet H.C. Wainwright Buy
2022-01-06 Eingeleitet William Blair Outperform
2021-11-18 Eingeleitet SMBC Nikko Outperform
2021-07-16 Eingeleitet Oppenheimer Outperform
2020-08-04 Eingeleitet Cowen Outperform
2020-08-04 Eingeleitet Evercore ISI Outperform
2020-08-04 Eingeleitet Mizuho Buy
2020-08-04 Eingeleitet Stifel Buy
Alle ansehen

Nkarta Inc Aktie (NKTX) Neueste Nachrichten

pulisher
Nov 27, 2025

Why Nkarta Inc. stock is favored by top institutionsRate Cut & Daily Entry Point Alerts - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 22, 2025

Nkarta: Pushing Deeper And Deeper Into A Discount Vs. Their Holdings, For No Real Reason - Seeking Alpha

Nov 22, 2025
pulisher
Nov 21, 2025

How interest rate cuts could boost Nkarta Inc. stockMarket Activity Report & Low Risk Growth Stock Ideas - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Why Nkarta Inc. stock appeals to dividend seekers2025 Retail Activity & High Accuracy Swing Entry Alerts - newser.com

Nov 21, 2025
pulisher
Nov 19, 2025

Using Python tools to backtest Nkarta Inc. strategiesWeekly Gains Summary & High Conviction Buy Zone Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Nkarta Inc. stock split again soonJuly 2025 Highlights & Risk Controlled Stock Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Nkarta Inc. stock benefits from strong dollarOil Prices & Reliable Trade Execution Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

A better buy-in window may exist right now for Nkarta Inc (NKTX) - Setenews

Nov 19, 2025
pulisher
Nov 19, 2025

What momentum indicators show for Nkarta Inc. stockTrade Analysis Summary & Daily Profit Maximizing Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is it time to cut losses on Nkarta Inc.Product Launch & Comprehensive Market Scan Reports - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Will Nkarta Inc. stock deliver strong dividend growthSwing Trade & Free Expert Verified Stock Movement Alerts - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Nkarta, Inc.Common Stock (NQ: NKTX - FinancialContent

Nov 18, 2025
pulisher
Nov 16, 2025

Will Nkarta Inc. stock sustain high P E ratiosJuly 2025 Intraday Action & Short-Term Trading Alerts - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Nkarta reports Q3 EPS (29c), consensus (30c) - MSN

Nov 16, 2025
pulisher
Nov 15, 2025

Nkarta Inc. stock prediction for this weekJuly 2025 Summary & Daily Price Action Insights - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Will Nkarta Inc. stock beat EPS estimatesPortfolio Risk Report & Safe Entry Zone Tips - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

Published on: 2025-11-14 17:50:20 - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

What is William Blair’s Forecast for Nkarta FY2025 Earnings? - Defense World

Nov 14, 2025
pulisher
Nov 14, 2025

Q1 Earnings Estimate for Nkarta Issued By Leerink Partnrs - Defense World

Nov 14, 2025
pulisher
Nov 14, 2025

William Blair Forecasts Nkarta’s Q1 Earnings (NASDAQ:NKTX) - Defense World

Nov 14, 2025
pulisher
Nov 14, 2025

FY2025 EPS Estimates for Nkarta Lifted by Leerink Partnrs - Defense World

Nov 14, 2025
pulisher
Nov 13, 2025

Published on: 2025-11-13 17:41:50 - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Risk adjusted return profile for Nkarta Inc. analyzedWeekly Trade Review & Free Fast Entry Momentum Trade Alerts - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

HC Wainwright Forecasts Nkarta’s Q1 Earnings (NASDAQ:NKTX) - Defense World

Nov 13, 2025
pulisher
Nov 13, 2025

Nkarta CEO Paul Hastings sells $38,231 in stock - MSN

Nov 13, 2025
pulisher
Nov 12, 2025

Nkarta price target lowered to $11 from $12 at Stifel - MSN

Nov 12, 2025
pulisher
Nov 12, 2025

Nkarta (NKTX) Receives a Buy from H.C. Wainwright - The Globe and Mail

Nov 12, 2025
pulisher
Nov 12, 2025

Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), BioLife Solutions (BLFS) and Cardiff Oncology (CRDF) - The Globe and Mail

Nov 12, 2025
pulisher
Nov 12, 2025

Published on: 2025-11-12 02:36:29 - newser.com

Nov 12, 2025
pulisher
Nov 11, 2025

Nkarta (NKTX) Upgraded to Buy: Here's Why - MSN

Nov 11, 2025

Finanzdaten der Nkarta Inc-Aktie (NKTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$39.84
price up icon 0.76%
$31.92
price up icon 1.66%
$105.65
price up icon 0.09%
$102.70
price up icon 3.00%
biotechnology ONC
$340.64
price up icon 1.63%
$204.51
price down icon 2.16%
Kapitalisierung:     |  Volumen (24h):